Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
- Conditions
- Parkinson Disease
- Registration Number
- NCT06719583
- Lead Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Brief Summary
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities.
BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
- Detailed Description
Research studies have found connections between genes and Parkinson's disease (PD). But those results have mostly come from studies with non-Black or African American volunteers. BLAAC PD aims to learn more about gene changes that may cause Parkinson's in Black and African American people. Study volunteers at sites across the United States will attend one visit and will give either a blood or saliva sample, complete a smell test, and may be asked to complete a physical exam. This new data could lead to future Parkinson's tests and treatments for Black and African American people and it may help better understand disease in other groups, too.
This pioneering initiative will fill a gap of knowledge about PD in Black and African American people.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Explore novel risk factors and characterization 5 years To explore novel risk factors and characterization of known genetic risk factors contributing to Parkinson's disease risk in the Black and African American population.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (12)
University of Alabama at Birmingham
๐บ๐ธBirmingham, Alabama, United States
University of Florida
๐บ๐ธGainesville, Florida, United States
Rush University
๐บ๐ธChicago, Illinois, United States
University of Chicago
๐บ๐ธChicago, Illinois, United States
Ochsner Clinic Foundation
๐บ๐ธNew Orleans, Louisiana, United States
Louisiana State University Health Sciences Center Shreveport
๐บ๐ธShreveport, Louisiana, United States
University of Maryland
๐บ๐ธBaltimore, Maryland, United States
Kaiser Permanente Midatlantic States
๐บ๐ธRockville, Maryland, United States
Washington University in St. Louis
๐บ๐ธSaint Louis, Missouri, United States
University Hospitals Cleveland Medical Center
๐บ๐ธCleveland, Ohio, United States
Medical University of South Carolina
๐บ๐ธCharleston, South Carolina, United States
University of Texas Health Science Center, Houston
๐บ๐ธHouston, Texas, United States